Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
47.82 USD | -0.80% | -19.26% | -42.72% |
May. 29 | Truist Securities Lowers Price Target on Cytokinetics to $70 From $86, Maintains Buy Rating | MT |
May. 28 | Cytokinetics Closes $500 Million Stock Offering | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-42.72% | 5.06B | |
+8.38% | 115B | |
+10.13% | 105B | |
-11.69% | 22.71B | |
+2.21% | 21.83B | |
-10.88% | 18.18B | |
-41.90% | 16.52B | |
-16.00% | 16.01B | |
+2.28% | 14.14B | |
+20.54% | 10.71B |
- Stock Market
- Equities
- CYTK Stock
- News Cytokinetics, Incorporated
- Cytokinetics Q4 Net Loss Narrows, Revenue Decreases; 2024 Outlook Issued